A role for HDAC6 in leptin sensitivity

被引:0
|
作者
Claire Greenhill
机构
[1] Nature Reviews Endocrinology,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:194 / 194
相关论文
共 50 条
  • [21] The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
    Spallotta, Francesco
    Illi, Barbara
    BIOMEDICINES, 2024, 12 (11)
  • [22] HDAC6 in Diseases of Cognition and of Neurons
    LoPresti, Patrizia
    CELLS, 2021, 10 (01) : 1 - 15
  • [23] HDAC6 score: to treat or not to treat?
    Hey, Joschka
    Prada, Maria Llamazares
    Plass, Christoph
    NATURE CANCER, 2023, 4 (02) : 156 - 158
  • [24] HDAC6 at the Intersection of Neuroprotection and Neurodegeneration
    d'Ydewalle, Constantin
    Bogaert, Elke
    Van Den Bosch, Ludo
    TRAFFIC, 2012, 13 (06) : 771 - 779
  • [25] QSAR Analysis of HDAC6 Inhibitors
    Tinkov, O. V.
    Grigorev, V. Yu.
    Grigoreva, L. D.
    MOSCOW UNIVERSITY CHEMISTRY BULLETIN, 2022, 77 (SUPPL 1) : S25 - S35
  • [26] HDAC6 score: to treat or not to treat?
    Joschka Hey
    Maria Llamazares Prada
    Christoph Plass
    Nature Cancer, 2023, 4 : 156 - 158
  • [27] QSAR Analysis of HDAC6 Inhibitors
    O. V. Tinkov
    V. Yu. Grigorev
    L. D. Grigoreva
    Moscow University Chemistry Bulletin, 2022, 77 : S25 - S35
  • [28] Role of Selective HDAC6 Inhibition On Multiple Myeloma Bone Disease
    Santo, Loredana
    Cirstea, Diana
    Wang, Bin
    Yao, Tso-Pang
    Wu, Joy Y.
    Waterman, Peter
    Jeon, Derrick
    Bouxsein, Mary
    Louis, Leeann
    Lotinun, Sutada
    Baron, Roland
    Eda, Homare
    Nemani, Neeharika
    Mahindra, Anuj
    Yee, Andrew J.
    Hideshima, Teru
    Anderson, Kenneth C.
    Jones, Simon S.
    Raje, Noopur
    BLOOD, 2012, 120 (21)
  • [29] HDAC6: A unique HDAC family member as a cancer target
    Sumeet Kaur
    Prerna Rajoria
    Madhu Chopra
    Cellular Oncology, 2022, 45 : 779 - 829
  • [30] HDAC6: A unique HDAC family member as a cancer target
    Kaur, Sumeet
    Rajoria, Prerna
    Chopra, Madhu
    CELLULAR ONCOLOGY, 2022, 45 (05) : 779 - 829